Michael W. Shackelford is a Shareholder in Buchalter’s Portland office and a Member of the firm’s Corporate Practice Group. Mr. Shackelford’s corporate practice focuses on counseling and business transactions, including mergers, acquisitions, divestitures, equity financings and joint ventures for privately-held and family-owned businesses in a variety of industries, including the technology, manufacturing, healthcare, bioscience and food processing industries.

Mr. Shackelford also assists businesses with the design, implementation and administration of equity-based, incentive compensation plans and arrangements, including stock options, restricted stock, stock appreciation rights, phantom stock and restricted stock units.

In addition, Mr. Shackelford has an estate planning practice, where he assists clients with estate and business succession planning, including preparation of wills, trust agreements and powers of attorney, to facilitate protection and management of personal and business assets during their lifetime and accomplish desired transfers of wealth at the end of their life.

Mr. Shackelford has been listed in Oregon Super Lawyers magazine from 2006 through 2009 and 2012 through 2018.  He has also been selected by his peers for inclusion in the Best Lawyers in America 2015 through 2024 in the field of Corporate Law.

Bar Admissions

• Oregon

Education

• Willamette University College of Law
• Willamette University

Significant Accomplishments

• Represented a gasoline and diesel fuel transportation company in its corporate reorganization followed by the sale of all the holding company’s outstanding stock to its newly formed ESOP.
• Represented a regional hospital system in its acquisition of a chain of on-demand urgent care health clinics.
• Represented a business-to-business automated payments company in its Series F Preferred Stock growth capital financing and subsequent sale to a strategic buyer.
• Represented a food processor in its restructuring and sale of controlling interest to a private equity fund.
• Represented co-founder of a test and measurement company in the redemption of his controlling interest.
• Represented key employees of public/government relations company in the purchase of all stock from the company’s founders.
• Represented a bioscience research and development company in its sale to a strategic buyer.